EUTM file information

018894254

SNaP

June 27, 2023

Trademark Summary

The trademark SNaP was filed by Ethris GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on July 3, 2023, and received one opposition filed on October 2, 2023 by IDEXX LABORATORIES, INC. on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. the opponent was represented by FISH & RICHARDSON P.C. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 2, 2023

The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on September 26, 2023.

Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Preservatives for pharmaceuticals
    2. Chemical substances, chemical materials and chemical preparations, and natural elements
    3. Detergents for use in manufacture and industry
    4. Salts for industrial purposes
    5. Chemical and organic compositions for use in the manufacture of food and beverages
    6. Aqueous chemical compositions
    7. Triglycerides
    8. Nucleic recombinant acids
    9. Nucleic acids
    10. Nucleic acids for scientific purposes
    11. Pyrimidine
    12. Lipids for use in manufacture
    13. Hydrosoluble polymers
    14. Polymer dispersions
    15. Biodegradable polymer compositions
    16. Hydrogel polymer coatings
    17. Cationic polymers
    18. Polymer solutions
    19. Aqueous polymer dispersions
    20. Fatty acid esters.
  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceuticals
    2. Pharmaceutical drugs
    3. Dermatological pharmaceutical products
    4. Pharmaceutical preparations
    5. Dermatological pharmaceutical substances
    6. Pharmaceutical compositions
    7. Antidiabetic pharmaceuticals
    8. Anti-diabetic pharmaceuticals
    9. Cardiovascular pharmaceuticals
    10. Injectable pharmaceuticals
    11. Tissue-regenerative pharmaceutical preparations
    12. Cardiovascular pharmaceutical preparations
    13. Antibacterial pharmaceuticals
    14. Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension
    15. Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
    16. Anaesthetic preparations for inhalation
    17. Pharmaceutical preparations for inhalers
    18. Sanitary preparations and articles
    19. Hygienic preparations and articles
    20. Air deodorising and air purifying preparations
    21. Dental preparations and articles
    22. Dental preparations and articles, and medicated dentifrices
    23. Dietary supplements and dietetic preparations
    24. Pest control preparations and articles
    25. Pharmaceutical preparations for the treatment of kidney diseases
    26. Respiratory stimulants
    27. Compounds for treating correlated pulmonary syndromes
    28. Medicines for the treatment of cardiovascular and cerebrovascular diseases
    29. Fertility enhancement preparations
    30. Pharmaceutical preparations for regulating the immune system
    31. Pharmaceutical preparations for the prevention of diseases of the immune system
    32. Pharmaceutical preparations for the prevention of disorders of the immune system
    33. Pharmaceutical preparations for the treatment of immune system related diseases and disorders
    34. Pharmaceutical preparations for the treatment of autoimmune diseases
    35. Pharmaceutical preparations for the prevention of autoimmune diseases
    36. Pharmaceutical preparations for the treatment of autoimmune disorders
    37. Pharmaceutical preparations for the prevention of autoimmune disorders
    38. Autoantigens
    39. Vaccines
    40. Vaccine preparations
    41. Vaccine adjuvants
    42. Veterinary vaccines
    43. Vaccines against pneumococcal infections
    44. Viral vaccines
    45. Human vaccine preparations
    46. Vaccines against flu
    47. Oral vaccine preparations
    48. Antiviral drugs for treating influenza
    49. Vaccines for human use
    50. Fat emulsions for medical infusions
    51. Medical preparations
    52. Medicinal healthcare preparations
    53. Medicinal infusions
    54. Infusions (Medicinal -)
    55. Medicinal preparations and substances
    56. Medicine
    57. Serotherapeutic medicines
    58. Antiallergic medicines
    59. Medicines for animals
    60. Nucleic acid sequences for medical and veterinary purposes
    61. Acids for pharmaceutical purposes
    62. Adjuvants for medical purposes
    63. Cellular function activating agents for medical purposes
    64. Chemical preparations for medical purposes
    65. Chemical preparations for veterinary purposes
    66. Nasal sprays for medical purposes
    67. Medicated nasal spray preparations
    68. Pharmaceutical preparations for the treatment of cancer
    69. Biological preparations for the treatment of cancer
    70. Biopharmaceuticals for the treatment of cancer
    71. Pharmaceutical products for the treatment of cancer
    72. Pharmaceutical preparations and substances for the treatment of cancer
    73. Pharmaceutical preparations and substances for the prevention of cancer
    74. Compounds for treating cancer
    75. Pharmaceutical preparations for activating cellular function
    76. Vaccines for cattle
    77. Vaccines for horses
    78. Veterinary vaccines for bovine animals
    79. Pharmaceutical preparations for the treatment of osteoporosis
    80. Pharmaceutical preparations for the treatment of hyperlipidemia
    81. Pharmaceutical preparations for the treatment of hypercholesteremia
    82. Pharmaceutical preparations for the prevention of osteoporosis
    83. Pharmaceutical preparations for the prevention of inflammatory diseases
    84. Pharmaceutical preparations for the prevention of allergies
    85. Pharmaceutical preparations for the prevention of diseases of the cardio-vascular system
    86. Pharmaceutical preparations for the prevention of diseases of the musculo-skeletal system
    87. Pharmaceutical preparations for the prevention of diseases of the respiratory system
    88. Pharmaceutical preparations for the prevention of inflammatory disorders
    89. Pharmaceutical preparations for the prevention of diseases of the genitourinary system
    90. Pharmaceutical preparations for the prevention of diabetes
    91. Pharmaceutical preparations for the prevention of diseases caused by bacteria
    92. Pharmaceutical preparations for treating arthritis
    93. Medicated ointments for treating dermatological conditions
    94. Medicated lotions for treating dermatological conditions
    95. Medicated creams for treating dermatological conditions
    96. Pharmaceutical preparations for treating gastrointestinal disorders
    97. Pharmaceutical preparations for treating chloasma
    98. Pharmaceutical preparations for treating diabetes
    99. Pharmaceutical preparations and substances
    100. Bronchodilating preparations
    101. Organotherapeutic preparations
    102. Chemico-pharmaceutical preparations.
  • The mark was filed in class 42 with following description of goods:
    1. Research of pharmaceuticals
    2. Pharmaceutical drug development services
    3. Development of pharmaceutical preparations and medicines
    4. Research and development of vaccines and medicines
    5. Vaccine research and development services
    6. Research and development services relating to vaccines
    7. Development of gene-based medicines
    8. Gene therapy research
    9. Research in the field of gene therapy
    10. Laboratory research in the field of gene expression
    11. Research in the field of gene editing technology
    12. Research and development services in the field of gene expression systems
    13. Advisory services relating to gene therapy research
    14. Biotechnology research
    15. Research and development in the pharmaceutical and biotechnology fields
    16. Biotechnology testing
    17. Scientific research relating to biology
    18. Scientific research in the field of genetics and genetic engineering
    19. Animal genetics research
    20. Research relating to molecular sciences
    21. Information on the subject of scientific research in the field of biochemistry and biotechnology
    22. Scientific research in the field of genetics
    23. Scientific research relating to genetics.
  • The mark was filed in class 44 with following description of goods:
    1. Preparation and dispensing of medications
    2. Fertility treatment
    3. Human fertility treatment services
    4. Vaccination services
    5. Regenerative medicine services
    6. Dispensing of pharmaceuticals
    7. Therapy services
    8. Medical treatment services.